Psychologists in Waynesville, NC Accepting Medicare
11 Psychologists found. Showing 1 - 11
 Arthur J. Dosch, HSP-PA Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 91 Timberlane Rd, Waynesville, NC 28786 Phone: 828-454-1098 Fax: 828-454-9242 |
 Dr. Marsha Hammond, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1207 East St, Waynesville, NC 28786 Phone: 404-964-5338 Fax: 828-253-2066 |
Mr. David Emmit Thompson, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 407 Welch St, Waynesville, NC 28786 Phone: 828-421-9324 |
Ashley Toler, LPA Psychologist Medicare: Accepting Medicare Assignments Practice Location: 669 S Haywood St, Waynesville, NC 28786 Phone: 828-631-3973 Fax: 828-631-9280 |
Dr. Raymond Carroll Turpin Iii, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 52 Walnut St Ste 4, Waynesville, NC 28786 Phone: 828-226-2352 |
Dr. Amy Elizabeth Parrish, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 28 Walnut St, Suite 3, Waynesville, NC 28786 Phone: 828-712-9579 |
Elizabeth Lynne Howard Noonan, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 66 Walnut St # 3, Waynesville, NC 28786 Phone: 828-454-5253 Fax: 828-454-0217 |
Ms. Melissa K Hamm, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 91 Timberlane Rd, Waynesville, NC 28786 Phone: 828-454-1098 Fax: 877-346-1089 |
Prof. Cathy Lauren Grist, M.A. Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 274 East St, Waynesville, NC 28786 Phone: 828-226-7372 Fax: 828-227-7021 |
Dr. Tiffany Dawn Simpson, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 13 Forga Plaza Loop, Waynesville, NC 28786 Phone: 219-689-7632 |
Dr. Todd Morton, PH D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 166 Branner Ave, Waynesville, NC 28786 Phone: 828-508-1705 |
News Archive
Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
Research reveals potential early indicator of Fragile X-associated tremor/ataxia syndrome
A new paper in the journal NeuroImage: Clinical from researchers at the University of Kansas reveals a possible early indicator of Fragile X-associated tremor/ataxia syndrome, or FXTAS.
ATA recognizes 4th Annual World Thyroid Day
The American Thyroid Association, in cooperation with sister international thyroid societies, the European Thyroid Association, the Asia & Oceania Thyroid Association, and the Latin American Thyroid Society, recognizes the 4th Annual World Thyroid Day, May 25, 2011.
Philips selects Acuo as partner for multi-site federated vendor neutral archive in UK
Acuo Technologies, the world leader in high-performance software and services for clinical content management and data migration, announced today it has been selected as the preferred supplier to work with technology partner and prime contractor Philips in the United Kingdom to implement a multi-site federated vendor neutral archive, featuring fully-distributed data management with centralized administration, to be shared across six NHS trusts in Surrey and Sussex.
Caffeine consumption may prolong lives of kidney disease patients
Caffeine consumption may prolong the lives in patients with chronic kidney disease (CKD), according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
› Verified 2 days ago
Counselors
Clinical Social Workers
Pharmacists
Dentists
Psychologists
Occupational Therapists